Literature DB >> 1630613

The reversal sign.

G Vergote1, H Vandeperre, R De Man.   

Abstract

We report a 36-year-old woman with a bacterial meningitis. CT after resuscitation showed a striking "reversal sign." Opinions on the pathogenesis of this sign are discussed; it indicates serious brain damage and carries a poor prognosis.

Entities:  

Mesh:

Year:  1992        PMID: 1630613     DOI: 10.1007/bf00596339

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  3 in total

1.  Pathophysiology of "reverse" edema in global cerebral ischemia.

Authors:  C R Bird; B P Drayer; F H Gilles
Journal:  AJNR Am J Neuroradiol       Date:  1989 Jan-Feb       Impact factor: 3.825

2.  Early CT findings of global central nervous system hypoperfusion.

Authors:  B O Kjos; M Brant-Zawadzki; R G Young
Journal:  AJR Am J Roentgenol       Date:  1983-12       Impact factor: 3.959

3.  Reversal sign on CT: effect of anoxic/ischemic cerebral injury in children.

Authors:  B K Han; R B Towbin; G De Courten-Myers; R L McLaurin; W S Ball
Journal:  AJNR Am J Neuroradiol       Date:  1989 Nov-Dec       Impact factor: 3.825

  3 in total
  4 in total

Review 1.  [Craniocerebral trauma. 2: Intra-axial injuries, secondary injuries].

Authors:  T Struffert; C Axmann; W Reith
Journal:  Radiologe       Date:  2003-11       Impact factor: 0.635

2.  The Reversal Sign: An Ominous Imaging Finding.

Authors:  Carolina B Maciel; Randy S D'Amico; Ajay Gupta
Journal:  Neurohospitalist       Date:  2015-10

3.  'White cerebellar sign' in immediate postpartum period.

Authors:  Virender Malik; T V S P Murthy; Vikas Raj; Suman Vyas; U S S V Mehar
Journal:  Med J Armed Forces India       Date:  2014-01-25

4.  Resting State-fMRI with ReHo Analysis as a Non-Invasive Modality for the Prognosis of Cirrhotic Patients with Overt Hepatic Encephalopathy.

Authors:  Wei-Che Lin; Tun-Wei Hsu; Chao-Long Chen; Cheng-Hsien Lu; Hsiu-Ling Chen; Yu-Fan Cheng
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.